Valuation: BioNTech SE

Market Cap 2.05TCr 2.34TCr 1.91TCr 1.76TCr 3.29TCr 2,23400Cr 3.35TCr 23TCr 8.87TCr 1,10800Cr 8.78TCr 8.59TCr 3,82700Cr P/E 2026 *
-18.5x
P/E 2027 * -17.8x
Enterprise Value 966.74Cr 1.1TCr 900.24Cr 828.01Cr 1.55TCr 1,05200Cr 1.58TCr 11TCr 4.18TCr 52TCr 4.14TCr 4.05TCr 1,80300Cr EV / Sales 2026 *
4.46x
EV / Sales 2027 * 5.04x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day+1.49%
1 week+0.13%
Current month-0.64%
1 month+1.35%
3 months-9.42%
6 months-20.41%
Current year-2.89%
1 week 88.5
Extreme 88.5
92.71
1 month 88.35
Extreme 88.35
98.81
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 60 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 55 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
12/05/26 Free

Executive/Senior Manager

22,655 0.0094%
12/05/26 Free

Chief Operating Officer

22,655 0.0094%
12/05/26 Free

Chief Financial Officer

33,982 0.0141%
Change 5-day change 1-year change 3-year change Capi.($)
+1.49%+0.13%-18.03%-13.94% 2.34TCr
-2.25%+1.55%+50.84%+70.04% 5.5TCr
-1.32%-2.71%+34.27%+77.57% 5.42TCr
-0.57%-4.13%+2.34%+387.73% 2.26TCr
+1.92%+1.18%+16.96%-10.88% 2.02TCr
0.00%+3.00%+27.41%-29.52% 1.79TCr
-4.11%-5.45%+24.00%+546.99% 1.55TCr
-6.69%-5.11%+169.13%+304.89% 1.42TCr
+1.25%+0.69%+27.30%+184.69% 1.42TCr
-2.26%-1.46%+83.17%+162.18% 1.24TCr
Average -1.23%-0.31%+41.74%+167.97% 2.5TCr
Weighted average by Cap. -1.21%-0.35%+37.32%+132.96%

Financials

2026 *2027 *
Net sales 216.8Cr 247.03Cr 201.88Cr 185.69Cr 348.08Cr 24TCr 354.05Cr 2.4TCr 937.47Cr 12TCr 927.42Cr 907.38Cr 40TCr 223.08Cr 254.19Cr 207.73Cr 191.06Cr 358.16Cr 24TCr 364.31Cr 2.46TCr 964.63Cr 12TCr 954.28Cr 933.67Cr 42TCr
Net income -104.43Cr -119Cr -97Cr -89Cr -167.67Cr -11TCr -170.55Cr -1.15TCr -451.58Cr -5.64TCr -446.74Cr -437.09Cr -19TCr -116.46Cr -132.71Cr -108.45Cr -100Cr -186.99Cr -13TCr -190.2Cr -1.29TCr -503.61Cr -6.29TCr -498.21Cr -487.45Cr -22TCr
Net Debt -1.09TCr -1.24TCr -1.01TCr -929.31Cr -1.74TCr -1,18100Cr -1.77TCr -12TCr -4.69TCr -59TCr -4.64TCr -4.54TCr -2,02400Cr -928.13Cr -1.06TCr -864.29Cr -794.94Cr -1.49TCr -1,01000Cr -1.52TCr -10TCr -4.01TCr -50TCr -3.97TCr -3.88TCr -1,73100Cr
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
28/26/28 $92.45 +1.49% 6,79,283
27/26/27 $91.09 +1.97% 6,87,342
24/26/24 $89.33 -2.97% 8,86,104
23/26/23 $92.06 +0.25% 5,39,216
22/26/22 $91.83 -0.54% 5,08,360
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
81.13EUR
Average target price
107.04EUR
Spread / Average Target
+31.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock